<DOC>
	<DOCNO>NCT03068949</DOCNO>
	<brief_summary>This study evaluate detail way immune system respond three different kind flu shot license United States .</brief_summary>
	<brief_title>Comparison Three Licensed Influenza Vaccines</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Aged 18 49 year age ( inclusive ) . 2 . Female subject must fulfill one following : ( ) able bear child surgically sterilize ( tubal ligation hysterectomy ) ( ii ) agree practice effective method contraception may include , limited abstinence , barrier method , monogamous relationship vasectomize partner , birth control pill , patch , hormonal shot hormonal implant , NuvaRing IUDs ( intrauterine device ) , 30 day prior study enrollment 30 day follow receipt last dose vaccine . 3 . Female subject childbearing potential must negative pregnancy test ( urine serum ) within 24 hour prior vaccination . 4 . The subject must good health , determine : vital sign ( heart rate &gt; 55 &lt; 100 bpm ; blood pressure : systolic ≥ 90 mm Hg ≤150 mm Hg ; diastolic ≤ 90 mm Hg ; oral temperature &lt; 100.0ºF ) ; medical history ; target physical examination , necessary , base medical history . Stable medical condition define : recent increase prescription medication , dose , frequency medication last 3 month health outcome specific disease consider within acceptable limit last 6 month . 5 . The subject able understand comply plan study procedure , include available study visit . 6 . The subject provide informed consent prior study procedure . 7 . Subjects receive seasonal flu vaccine current year . Exclusion Criteria 1 . Subject report know hypersensitivity allergy component study vaccine component study vaccine . 2 . Subject report know latex allergy 3 . Subject report history severe reaction follow previous immunization license unlicensed influenza virus vaccine . 4 . Subject report history GuillainBarre syndrome within 6 week receipt previous influenza vaccine . 5 . The subject woman pregnant breastfeeding intend become pregnant study period enrollment 30 day follow receipt vaccine . 6 . The subject immunosuppressed result underlie illness treatment immunosuppressive cytotoxic drug , use anticancer chemotherapy radiation therapy within precede 36 month . 7 . The subject active neoplastic disease ( exclude nonmelanoma skin cancer prostate cancer stable absence therapy ) history hematological malignancy . For criterion , `` active '' define receive treatment within past 5 year . 8 . The subject longterm ( great 2 week ) use oral parenteral steroid , highdose inhaled steroid ( &gt; 800 mcg/day beclomethasone dipropionate equivalent ) within precede 6 month ( nasal topical steroid allow ) . 9 . The subject receive immunoglobulin another blood product within 3 month prior enrollment study . 10 . The subject receive inactivated vaccine within 2 week live vaccine within 4 week prior enrollment study plan receive another vaccine within next 28 day . 11 . The subject acute chronic medical condition , opinion investigator appropriate subinvestigator , would render vaccination unsafe would interfere evaluation response . These condition include acute chronic medical disease condition define persist 3 month ( defines ad 90 day ) long , would place subject unacceptable risk injury , render subject unable meet requirement protocol , may interfere evaluation response subject 's successful completion study . 12 . Subjects active infection acute illness oral temperature great 99.9F ( 37.7C ) within 3 day prior enrollment vaccination . Subjects acute illness treat symptom resolve eligible enroll long treatment complete symptom resolve &gt; 3 day prior enrollment . 13 . The subject currently participate plan participate study involve experimental agent ( vaccine , drug , biologic , device , blood product , medication ) receive experimental agent within 1 month prior enrollment study , expect receive another experimental agent participation study , intend donate blood study period . 14 . The subject condition would , opinion site investigator , place subject unacceptable risk injury render subject unable meet requirement protocol . 15 . Have hospitalize psychiatric illness , history suicide attempt , confinement danger self others , within past 10 year . 16 . The subject diagnosis schizophrenia , bipolar disease , severe ( disable ) chronic psychiatric diagnosis , receive psychiatric drug . Subjects receive single antidepressant drug stable least 3 month prior enrollment without decompensation allow enrollment study . 17 . The subject history alcohol drug abuse 5 year prior enrollment . 18 . The subject know human immunodeficiency virus , hepatitis B , hepatitis C infection . 19 . The subject condition principal investigator ( PI ) believe may interfere successful completion study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>